Skip to main content

UK University Taps Dotmatics ELN to Support Drug Discovery Research

Premium

Dotmatics said this week that University of Sussex has added Studies Notebook, the company's web-based electronic laboratory notebook, to its existing Dotmatics data management platform.

The software Dotmatics provides supports ongoing projects from the university's translational drug discovery group in areas such as hit identification and lead optimization. Simon Ward, a professor of medicinal chemistry and co-director of the group, said that the company's products enable "us to work very effectively and to process and analyze data in a highly efficient manner."

John Atack, a professor of molecular pharmacology and group co-director, described Dotmatics' platform as "a fully optimized and perfectly integrated addition to our existing chemoinformatics platform." It enables "us to access all of our data in a single web-based platform and allows our scientists to streamline their data entry, triage, and analysis," he said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.